# Filing Detail

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001171843-21-002040
Filing Date
2021-03-24
Accepted
2021-03-24 17:01:09
Documents
155
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 20-F/A | f20fa_032521.htm | 20-F/A | 2411693
2 | EXHIBIT 12.1 | exh_121.htm | EX-12.1 | 6782
3 | EXHIBIT 12.2 | exh_122.htm | EX-12.2 | 7176
4 | EXHIBIT 13.1 | exh_131.htm | EX-13.1 | 3539
5 | EXHIBIT 13.2 | exh_132.htm | EX-13.2 | 3634
12 | GRAPHIC | p67.jpg | GRAPHIC | 43026
13 | GRAPHIC | p68.jpg | GRAPHIC | 31125
14 | GRAPHIC | p69.jpg | GRAPHIC | 29088
15 | GRAPHIC | p71.jpg | GRAPHIC | 35434
16 | GRAPHIC | p72.jpg | GRAPHIC | 81392
17 | GRAPHIC | p73.jpg | GRAPHIC | 51312
18 | GRAPHIC | p74a.jpg | GRAPHIC | 35675
19 | GRAPHIC | p74b.jpg | GRAPHIC | 33505
20 | GRAPHIC | p75a.jpg | GRAPHIC | 35889
21 | GRAPHIC | p75b.jpg | GRAPHIC | 41993
22 | GRAPHIC | p75c.jpg | GRAPHIC | 40189
23 | GRAPHIC | p77.jpg | GRAPHIC | 39800
24 | GRAPHIC | p99.jpg | GRAPHIC | 6939
| Complete submission text file | 0001171843-21-002040.txt |  | 22823220

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE FILE | iva-20201231.xml | EX-101.INS | 7767791
7 | XBRL SCHEMA FILE | iva-20201231.xsd | EX-101.SCH | 161395
8 | XBRL CALCULATION FILE | iva-20201231_cal.xml | EX-101.CAL | 92482
9 | XBRL DEFINITION FILE | iva-20201231_def.xml | EX-101.DEF | 428757
10 | XBRL LABEL FILE | iva-20201231_lab.xml | EX-101.LAB | 870630
11 | XBRL PRESENTATION FILE | iva-20201231_pre.xml | EX-101.PRE | 744389

Mailing Address 50 RUE DE DIJON DAIX I0 21121
Business Address 50 RUE DE DIJON DAIX I0 21121 33380447500
Inventiva S.A. (Filer) CIK: 0001756594 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-39374 | Film No.: 21768901
SIC: 2834 Pharmaceutical Preparations